pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1245b |
Genomic Coordinates | chr2: 188978093 - 188978161 |
Description | Homo sapiens miR-1245b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1245b-3p | ||||||||||||||||||
Sequence | 42| UCAGAUGAUCUAAAGGCCUAUA |63 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LRRC20 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | leucine rich repeat containing 20 | ||||||||||||||||||||
Transcript | NM_018205 | ||||||||||||||||||||
Other Transcripts | NM_018239 , NM_207119 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LRRC20 | |||||||||||||||||||||
3'UTR of LRRC20 (miRNA target sites are highlighted) |
>LRRC20|NM_018205|3'UTR 1 GCCACCCTCCTCATGCCCACCCAGCAAGGGACAGAGGCCACAGGCCTGGAACCCTGGAAGGGAGGGAGGCCCATGGGAGG 81 CCAAGCCTGGGGGCTGGGGGCGGGTGGGCCGAGCAGCACGTGGTGGGTGGGGTGCAGCTGGTCTGGATAGATAGCTTACA 161 GCAGTAGTGGGCTCTGGAATGCCCAAGGGAAGAGGCAAGGTGGGGCCTGCAGCCTGGACTCGGCACTCACAGCTGCTGTG 241 CAAACTCAGGCAGATCTCCTGCCCTCTCTGAGCCTTGTCACTTGAAAAAAACAGGACCCTTTCCCTCCTTTGGGCTCCCT 321 GGAGGTTTTTAAGCAGTACGTGCCTCCAAGTTACCTCCAGATCAGCAGGCACAGGTGGGCATTGCCAGGTATTTTCTGAG 401 CCCCTGCGGGTTTGAGGCCTTGTTTTTAGTGCTGAGAGCCAGTTGCTGCCCTGAGAAGAGAAGACAACCTCCATCTATTT 481 ATTGCTTCCTGAGAACTGACCTGGATGCGGCCCTCTGCAGGGCCCAGTCTTCAGTCCTGTGGTCCCTGGACTGGTGGGAA 561 CCTGAACTAGGAGTCCTGGGAGAGCTGTGGTGGGAATATGGGCTGGCACTGCTGCAGGGCAAGAACATTCATGTAGGAGC 641 CCGAGGACCAGCAGGCTGGGAATGGGGAGCAAGTCACGTCAGCTCTGTCATTCCCCACAGTTAACAAATTGGCGGGGTGG 721 GAAGTCCTGAGTGCTCCGTCCCTCTAGCATCACTCCTGAGCTGCGGGAGAGGTGGCCCAGAGAACAGCAGAGTCAGTTAC 801 ACCTGCAGCTCTTGTCTAAAGTGATTAGATGGCCACCCTCACCACTGTCCAGTCCAGCAGCAGCCTGGCTGCCTTGTCAT 881 GGCCTCCTGGGGGCAGAAGGCGATGTGGACCACGGGATTTGTAGCCAGCCAGCTCCCAGGCCAACGCCCAAAGCCCTGAT 961 GACCTGGTTCTTCTGAGGCCCTCAACCTGGCATCTTAGGGTATGGTCAGGCAACAGGGTGACCAGCTGTCCTGGTTTCCC 1041 AGGACATGGAACTTTCAATGCTAAAACTGGGACAGTACCCAGCAAGTGGGGATGGTTGGTCCCCTACCAGGAGAGGGCCT 1121 GGGGCTCTTGCTTCCCGAGAACGCCTGTGGCTTGAAGAACCTTGACTGCTTGGTCCTCAGGTATCTACCTCCCACCTTCT 1201 CCTCATCTGTGGAGCAAGCCAACTCAGTGCCCCAGACCCCACCTGATCTGCATCTTTGTTTGCATCTCCAGAGACACCTG 1281 AGGCCCCAGAGCTTGAGGCAAAGCCAGGCCGTCCAAATCCTGTGTGCCGTGGACGAGTGGCCACTTTACTACTCCTAAGG 1361 CTAAGATGTTGAGAGCTCAGACCACTGCTCAGAGCAGTAATCCCTGCTCAGAATGCTCCCAGTTCCCTCGTCCCTGCCCA 1441 GGTCTCTTGTCTCTTGGGAAGGAACTGATAGGTCGGGCCATTGTTGGGCCATCACTGAGCGCTCAGTATCTCAAGAGACT 1521 CTGTTCATTCTGCTCGTATCCCAAGGCCTGGTTGGTCAAACTCTGGGCAAAGGGTTTTCAGGATGAGGAGGTCAAGACAG 1601 GATCTCCAGAGCTACCGAGTTCATCTGTGGGTGTTGGGGGCAAGTGGGGGCTGAAGTCCTGTGCAGGCTGCGCTGGCCCC 1681 ACCTGCCTTGTGCCCTGGAGTGGGGTTTCTCCTTGTTGAAGAAGAGGCATCCTTCTCTGATGTGCACAAACACAATGTAT 1761 GACCAGAGCCTTGCAACTCAAAGTGTGGTCTGTGGACCAGCAGCGGCAGTGACACCTGGGAGCTTGTTAGGAATGCAGAG 1841 TCTAGGCCTCACCCTATACCTCCCGACTCAGACCCTGCATTTTAGCAAGACCCCCAGCTGATTCCTATAAGCACTTTAGA 1921 GTTTGAGAAGCAAGGACCTAGGCTGGGGATGTCCTCCGAGCAGAGGGTGAAGTTTCTCTCAGTTCTCTCCCTGCCACTTC 2001 CAGGGATCTGAGCCTGTGCTCAGCCTCCTCCCTAACCCACCCTGGGAGACACTTGGCCTGTTAGATTGTTCCAGAGTCTG 2081 CATGGCACTCCTGAAGAAGGGAGTGTGACCTGCAGTCACCAGGAGATGAGGGTTAGGTGTGCCCAGCCCTCCAGACCCGG 2161 CCTTTCTGGTTAACCCCTGCATGCCAAGCTGCCTGCTGCCCCAGGTCCTCACCTCAGGCCTTTGAAGGGGCAGCTTCTGG 2241 AAGTTGTTTTCTCCTCTGCTTGGAGAGTTTGCCCTTGTCTGTCTTGGAAAGTGTGGGCAGCCACAGATGCCCCCAAATCA 2321 GAGCTCACAGTGAGTGAGCCCCTAAGCTTCAGTCTGCAATAAAGAATGCATTGGTTTCATCTGCAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | TZM-bl | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000355790.4 | 3UTR | UCCUCAGGUAUCUACCUCCCACCUUCUCCUCAUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
62 hsa-miR-1245b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT087132 | CRKL | CRK like proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT093398 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT096092 | SFXN1 | sideroflexin 1 | 2 | 2 | ||||||||
MIRT097106 | TNPO1 | transportin 1 | 2 | 4 | ||||||||
MIRT241837 | SLC38A2 | solute carrier family 38 member 2 | 2 | 2 | ||||||||
MIRT271432 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT329517 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT444201 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT445920 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT450210 | PAIP1 | poly(A) binding protein interacting protein 1 | 2 | 2 | ||||||||
MIRT455192 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT455458 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT459016 | UQCRH | ubiquinol-cytochrome c reductase hinge protein | 2 | 2 | ||||||||
MIRT461492 | KIAA1009 | centrosomal protein 162 | 1 | 1 | ||||||||
MIRT466306 | TIMM22 | translocase of inner mitochondrial membrane 22 | 2 | 2 | ||||||||
MIRT471143 | PHF19 | PHD finger protein 19 | 2 | 2 | ||||||||
MIRT473481 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT473564 | MATR3 | matrin 3 | 2 | 2 | ||||||||
MIRT474013 | LRRC20 | leucine rich repeat containing 20 | 2 | 2 | ||||||||
MIRT475982 | GTPBP2 | GTP binding protein 2 | 2 | 2 | ||||||||
MIRT478926 | CPNE3 | copine 3 | 2 | 2 | ||||||||
MIRT479896 | CCDC117 | coiled-coil domain containing 117 | 2 | 2 | ||||||||
MIRT480115 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT483127 | ONECUT3 | one cut homeobox 3 | 2 | 2 | ||||||||
MIRT484236 | IER2 | immediate early response 2 | 2 | 2 | ||||||||
MIRT492237 | SLC48A1 | solute carrier family 48 member 1 | 2 | 2 | ||||||||
MIRT496934 | CAMK4 | calcium/calmodulin dependent protein kinase IV | 2 | 2 | ||||||||
MIRT500438 | ZMAT3 | zinc finger matrin-type 3 | 2 | 2 | ||||||||
MIRT506263 | PDPK1 | 3-phosphoinositide dependent protein kinase 1 | 2 | 2 | ||||||||
MIRT525649 | NHSL2 | NHS like 2 | 2 | 2 | ||||||||
MIRT526691 | BAK1 | BCL2 antagonist/killer 1 | 2 | 2 | ||||||||
MIRT529667 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT531152 | CYGB | cytoglobin | 2 | 2 | ||||||||
MIRT537002 | GTPBP10 | GTP binding protein 10 | 2 | 2 | ||||||||
MIRT537325 | FOXN3 | forkhead box N3 | 2 | 2 | ||||||||
MIRT537586 | ESYT2 | extended synaptotagmin 2 | 2 | 2 | ||||||||
MIRT538786 | C6orf89 | chromosome 6 open reading frame 89 | 2 | 2 | ||||||||
MIRT540286 | RGR | retinal G protein coupled receptor | 2 | 4 | ||||||||
MIRT552700 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 2 | 2 | ||||||||
MIRT555670 | PGAM4 | phosphoglycerate mutase family member 4 | 2 | 2 | ||||||||
MIRT556823 | KDELR2 | KDEL endoplasmic reticulum protein retention receptor 2 | 2 | 2 | ||||||||
MIRT568686 | TOMM40 | translocase of outer mitochondrial membrane 40 | 2 | 2 | ||||||||
MIRT568851 | VPS53 | VPS53, GARP complex subunit | 2 | 2 | ||||||||
MIRT571973 | KIF21A | kinesin family member 21A | 2 | 2 | ||||||||
MIRT573973 | DDX21 | DExD-box helicase 21 | 2 | 2 | ||||||||
MIRT574260 | DOCK7 | dedicator of cytokinesis 7 | 2 | 2 | ||||||||
MIRT612180 | EMC3 | ER membrane protein complex subunit 3 | 2 | 2 | ||||||||
MIRT619387 | KLHL12 | kelch like family member 12 | 2 | 2 | ||||||||
MIRT625708 | SHROOM1 | shroom family member 1 | 2 | 2 | ||||||||
MIRT646803 | EVC2 | EvC ciliary complex subunit 2 | 2 | 2 | ||||||||
MIRT656992 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT676250 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT682591 | CPA4 | carboxypeptidase A4 | 2 | 2 | ||||||||
MIRT687779 | KHSRP | KH-type splicing regulatory protein | 2 | 2 | ||||||||
MIRT690292 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT692718 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT700284 | RAN | RAN, member RAS oncogene family | 2 | 2 | ||||||||
MIRT708293 | ZNF24 | zinc finger protein 24 | 2 | 2 | ||||||||
MIRT709767 | GPR183 | G protein-coupled receptor 183 | 2 | 2 | ||||||||
MIRT720689 | LY6K | lymphocyte antigen 6 family member K | 2 | 2 | ||||||||
MIRT722784 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT725414 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|